Smart polymers in nasal drug delivery

Indian Journal of Pharmaceutical Sciences

Volumn 77, Issue 4, 2015, Pages 367-375

  Chonkar, Ankita ^a   Nayak, Usha ^a   Udupa, N ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

ion responsive; Nasal drug delivery; pH responsive; smart polymers; temperature responsive

Indexed keywords

CHITOSAN; MACROGOL; POLOXAMER; POLY(N ISOPROPYLACRYLAMIDE); POLYELECTROLYTE; POLYMER; POLYMETHACRYLIC ACID; POLYVINYL ALCOHOL; POLYVINYLACETAL DIETHYLAMINO ACETATE; UNCLASSIFIED DRUG;

DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; INTRANASAL DRUG ADMINISTRATION; MUCOADHESION; NOSE CAVITY; NOSE MUCOSA; PH; POLYMERIZATION; REVIEW; SYSTEMIC CIRCULATION; TEMPERATURE;

EID: 84941767392     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.164770     Document Type: Review

References (59)

1. Hearnden V, Sankar V, Hull K, Juras DV, Greenberg M, Kerr AR, et al. New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Adv Drug Deliv Rev 2012;64:16-28.
2. Jain KK, editor. Drug delivery systems-An overview. In: Drug Delivery Systems. 1st ed. Basel, Switzerland: Humana Press; 2008. p. 3.
3. Behl CR, Pimplaskar HK, Silenoy AP, deMeireles J, Romeo VD. Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv Drug Deliv Rev 1998;29:89-116.
4. Illum L. Nasal drug delivery: New developments and strategies. Drug Discov Today 2002;7:1184-9.
5. Sarkar MA. Drug metabolism in the nasal mucosa. Pharm Res 1992;9:1-9.
6. Ugwoke MI, Agu RU, Verbeke N, Kinget R. Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives. Adv Drug Deliv Rev 2005;57:1640-65.
7. Patel VF, Liu F, Brown MB. Advances in oral transmucosal drug delivery. J Control Release 2011;153:106-16.
8. Verma S, Kaul M, Rawat A, Saini S. An overview on buccal drug delivery system. Int J Pharm Sci Res 2011;2:1303-21.
9. Patwardhan S. Ayurveda-foryou.com; cc2000-14. Available from: http://ayurveda-foryou.com/panchakarma/nasya.html. [Last cited on 2014 Jan 10].
10. Hanson LR, Frey WH 2nd. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci 2008;9 Suppl 3:S5.
11. Kim DD. In vitro cellular models for nasal drug absorption studies. In: Ehrhardt C, Kim KJ, editors. Drug Absorption Studies: In Situ, In Vitro, In Silico Models. 1st ed. New York: Springer; 2008. p. 216-34.
12. Arora P, Sharma S, Garg S. Permeability issues in nasal drug delivery. Drug Discov Today 2002;7:967-75.
13. Nakamura F, Ohta R, Machida Y, Nagai T. In vitro and in vivo nasal mucoadhesion of some water-soluble polymers. Int J Pharm 1996;134:173-81.
14. Lindemann J, Leiacker R, Rettinger G, Keck T. Nasal mucosal temperature during respiration. Clin Otolaryngol Allied Sci 2002;27:135-9.
15. Cao SL, Ren XW, Zhang QZ, Chen E, Xu F, Chen J, et al. In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate. Int J Pharm 2009;365:109-15.
16. Madan M, Bajaj A, Lewis S, Udupa N, Baig JA. In situ forming polymeric drug delivery systems. Indian J Pharm Sci 2009;71:242-51.
17. Rahisuddin, Sharma PK, Garg G, Salim M. Review on nasal drug delivery system with recent advancement. Int J Pharm Pharm Sci 2011;3:6-11.
18. Escobar-Chávez JJ, López-Cervantes M, Naïk A, Kalia YN, Quintanar-Guerrero D, Ganem-Quintanar A. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci 2006;9:339-58.
19. Chiappetta DA, Sosnik A. Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugs. Eur J Pharm Biopharm 2007;66:303-17.
20. Basu S, Bandyopadhyay AK. Development and characterization of mucoadhesive in situ nasal gel of midazolam prepared with Ficus carica mucilage. AAPS PharmSciTech 2010;11:1223-31.
21. Pund S, Rasve G, Borade G. Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa. Eur J Pharm Sci 2013;48:195-201.
22. Bhalerao AV, Lonkar SL, Deshkar SS, Shirolkar SV, Deshpande AD. Nasal mucoadhesive in situ gel of ondransetron hydrochloride. Indian J Pharm Sci 2009;71:711-3.
23. Andrews GP, Laverty TP, Jones DS. Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm 2009;71:505-18.
24. Jadhav PP, Jadhav NR, Hosmani AH, Patil S. Development and evaluation of in situ thermoresponsive nasal gel system for Nardostachys jatamansi. Pharm Lett 2013;5:113-25.
25. Bromberg L. Poly(ethylene oxide)-b-poly(propylene oxide)-bpoly( ethylene oxide)-g-poly(acrylic acid) copolymers as in-situ vehicle for nasal delivery. In: Rathbene MJ, Hadgraft J, Roberts MS, editors. Modified Release Drug Technology. 1st ed. New York: Marcel Dekker; 2002. p. 749-58.
26. Bromberg LE. Enhanced nasal retention of hydrophobically modified polyelectrolytes. J Pharm Pharmacol 2001;53:109-14.
27. Ruel-Gariépy E, Leroux JC. In situ-forming hydrogels-Review of temperature-sensitive systems. Eur J Pharm Biopharm 2004;58:409-26.
28. Kun N, Bae YH. pH sensitive polymers for drug delivery. In: Kwon GS, editors. Polymeric Drug Delivery Systems. 1st ed. Florida, USA: Talor and Francis Group; 2005. p. 129-94.
29. Nazar H, Fatouros DG, van der Merwe SM, Bouropoulos N, Avgouropoulos G, Tsibouklis J, et al. Thermosensitive hydrogels for nasal drug delivery: The formulation and characterisation of systems based on N-trimethyl chitosan chloride. Eur J Pharm Biopharm 2011;77:225-32.
30. Chenite A, Chaput C, Cpmbes C, Selmani A, Jalal F. Temperature-Controlled pH-Dependant Formation of Ionic Polysaccharide Gels. US Patent 6344488; 2002.
31. Wu J, Wei W, Wang LY, Su ZG, Ma GH. A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system. Biomaterials 2007;28:2220-32.
32. Agrawal AK, Gupta PN, Khanna A, Sharma RK, Chandrawanshi HK, Gupta N, et al. Development and characterization of in situ gel system for nasal insulin delivery. Pharmazie 2010;65:188-93.
33. Zao J. Chitosan-based gels for the drug delivery system. In: Yao K, Li J, Yao F, Yin Y, editors. Chitosan-Based Hydrogels: Functions and Applications. 1st ed. USA: CRC Press; 2011. p. 263-314.
34. Jeong B, Kim SW, Bae YH. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 2002;54:37-51.
35. Rydén L, Edman P. Effect of polymers and microspheres on the nasal absorption of insulin in rats. Int J Pharm 1982;83:1-10.
36. Cho HJ, Balakrishnan P, Park EK, Song KW, Hong SS, Jang TY, et al. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride. J Pharm Sci 2011;100:681-91.
37. Mahajan HS, Shah SK, Surana SJ. Nasal in situ gel containing hydroxypropyl ?-cyclodextrin inclusion complex of artemether: Development and in vitro evaluation. J Incl Phenom Macrocycl Chem 2011;70:49-58.
38. Zaki NM, Awad GA, Mortada ND, Abd Elhady SS. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci 2007;32:296-307.
39. Majithiya RJ, Ghosh PK, Umrethia ML, Murthy RS. Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan. AAPS PharmSciTech 2006;7:67.
40. Park JS, Oh YK, Yoon H, Kim JM, Kim CK. In situ gelling and mucoadhesive polymer vehicles for controlled intranasal delivery of plasmid DNA. J Biomed Mater Res 2002;59:144-51.
41. Khan S, Patil K, Bobade N, Yeole P, Gaikwad R. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats. J Drug Target 2010;18:223-34.
42. Kim S, Nishimoto SK, Bumgardner JD, Haggard WO, Gaber MW, Yang Y. A chitosan/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer. Biomaterials 2010;31:4157-66.
43. Nandgude T, Thube R, Jaiswal N, Deshmukh P, Chatap V, Hire N. Formulation and evaluation pH induced in-situ nasal gel of salbutamol sulphate. Int J Pharm Sci Nanotechnol 2008;1:177-83.
44. Hornof MD, Kast CE, Bernkop-Schnürch A. In vitro evaluation of the viscoelastic properties of chitosan-thioglycolic acid conjugates. Eur J Pharm Biopharm 2003;55:185-90.
45. Nakamura K, Maitani Y, Lowman AM, Takayama K, Peppas NA, Nagai T. Uptake and release of budesonide from mucoadhesive, pH-sensitive copolymers and their application to nasal delivery. J Control Release 1999;61:329-35.
46. Aikawa K, Mitsutake N, Uda H, Tanaka S, Shimamura H, Aramaki Y, et al. Drug release from pH-response polyvinylacetal diethylamino acetate hydrogel, and application to nasal delivery. Int J Pharm 1998;168:181-8.
47. Aikawa K, Matsumoto K, Uda H, Tanaka S, Shimamura H, Aramaki Y. Hydrogel formation of the pH response polymer polyvinylacetal diethylamino acetate (AEA). Int J Pharm 1998;167:97-104.
48. Yuguchi Y, Urakawa H, Kitamura S, Wataoka I, Kajiwara K. The sol-gel transition of gellan gum aqueous solutions in the presence of various metal salts. Prog Colloid Polym Sci 1999;114:41-7.
49. Cao SL, Zhang QZ, Jiang XG. Preparation of ion-activated in situ gel systems of scopolamine hydrobromide and evaluation of its antimotion sickness efficacy. Acta Pharmacol Sin 2007;28:584-90.
50. Krauland AH, Leitner VM, Bernkop-Schnürch A. Improvement in the in situ gelling properties of deacetylated gellan gum by the immobilization of thiol groups. J Pharm Sci 2003;92:1234-41.
51. Illum L. Nasal drug delivery-Recent developments and future prospects. J Control Release 2012;161:254-63.
52. Watts P, Smith A. PecSys: In situ gelling system for optimised nasal drug delivery. Expert Opin Drug Deliv 2009;6:543-52.
53. www.medicines.org.uk. Datapharm Communications Ltd.; c2014. Available from: http://www.medicines.org.uk/emc/medicine/23962/SPC/ pecfent. [Last updated on 2014 Feb 28; Last cited on 2014 Mar 08].
54. Sriamornsak P. Chemistry of pectin and its pharmaceutical uses: A review. Silpakorn Univ J Soc Sci Humanit Arts 2003;3:206-23.
55. Fisher T, Knight A, Watling M, Smith A. Fentanyl pectin nasal spray (FPNS) with PecSys® provides most favorable pharmacokinetic/ tolerability profile compared with nasal chitosan-based fentanyl and oral transmucosal fentanyl citrate (OTFC). J Pain 2009;10 Suppl:S45.
56. Castile J, Cheng YH, Simmons B, Perelman M, Smith A, Watts P. Development of in vitro models to demonstrate the ability of PecSys®, an in situ nasal gelling technology, to reduce nasal run-off and drip. Drug Dev Ind Pharm 2013;39:816-24.
57. Cai Z, Hou SX, Yang ZX, Song XR, Chen QH, Li YB, et al. Brain targeting of gastrodin nasal in situ gel. Sichuan Da Xue Xue Bao Yi Xue Ban 2008;39:438-40.
58. Belgamwar VS, Chauk DS, Mahajan HS, Jain SA, Gattani SG, Surana SJ. Formulation and evaluation of in situ gelling system of dimenhydrinate for nasal administration. Pharm Dev Technol 2009;14:240-8.
59. Chen E, Chen J, Cao SL, Zhang QZ, Jiang XG. Preparation of nasal temperature-sensitive in situ gel of Radix bupleuri and evaluation of the febrile response mechanism. Drug Dev Ind Pharm 2010;36:490-6.